Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Digitalis: dead or alive?

P A Poole-Wilson1

  • 1National Heart Hospital, London, UK.

Cardiology
|January 1, 1988
PubMed
Summary
This summary is machine-generated.

Digoxin, derived from foxglove, was historically used for heart failure. Today, its primary role is managing rapid heart rates in atrial fibrillation, with diuretics and ACE inhibitors offering safer alternatives for heart failure treatment.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Resolution of central sleep apnoea following implantation of a left ventricular assist device.

International journal of cardiology·2008
Same author

A high prevalence of sleep disordered breathing in men with mild symptomatic chronic heart failure due to left ventricular systolic dysfunction.

European journal of heart failure·2006
Same author

Interventional versus conservative treatment in acute non-ST elevation coronary syndrome: time course of patient management and disease events over one year in the RITA 3 trial.

Heart (British Cardiac Society)·2006
Same author

ESC-CHF: guidelines for the aspirational and the practical.

Heart (British Cardiac Society)·2006
Same author

Can heart rate variation rule out sleep-disordered breathing in heart failure?

The European respiratory journal·2006
Same author

Diuretics for heart failure.

The Cochrane database of systematic reviews·2006
Same journal

Aortic Valve Sclerosis: More Than an Incidental Echocardiographic Finding.

Cardiology·2026
Same journal

Can resting segmental strain identify obstructive coronary artery disease in chronic coronary syndrome patients referred to CABG?

Cardiology·2026
Same journal

Mortality Impact of Stroke and Major Bleeding Across the Ejection Fraction Spectrum in Patients Hospitalized for Acute Heart Failure With Prevalent Atrial Fibrillation.

Cardiology·2026
Same journal

Impact of Inflammatory Disorders on Outcomes in Acute Heart Failure: A Nationwide Analysis.

Cardiology·2026
Same journal

Predictors and Clinical Impact of Tricuspid Regurgitation After Pericardiectomy for Constrictive Pericarditis.

Cardiology·2026
Same journal

Utilization of Guideline-Directed Medical Therapies and Transcatheter-Edge-to-Edge Repair in Patients with Significant Secondary Mitral Regurgitation.

Cardiology·2026
See all related articles

Area of Science:

  • Cardiology
  • Pharmacology

Background:

  • William Withering first described digitalis purpurea (foxglove) for heart failure over 200 years ago.
  • Digitalis purpurea extracts historically benefited patients with congestive heart failure, especially those with irregular rhythms.

Purpose of the Study:

  • To review the historical and current applications of digoxin in heart failure management.
  • To highlight the evolution of heart failure treatments.

Main Methods:

  • Historical review of the use of digitalis purpurea and its derivatives.
  • Comparison of digoxin with modern heart failure therapies.

Main Results:

  • Diuretics and angiotensin-converting enzyme inhibitors are now preferred for heart failure due to improved efficacy and safety.

Related Experiment Videos

  • The current indication for digoxin is primarily for rate control in patients with atrial fibrillation and heart failure.

    • Conclusions:

    • Digoxin's role in heart failure has significantly shifted from a primary treatment to a specialized therapy for rate control.
    • Modern pharmacotherapies offer superior treatment options for the management of congestive heart failure.